DSOL yields 142857.14% · PFE yields 6.13%● Live data
📍 DSOL pulled ahead of the other in Year 1
Combined, DSOL + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DSOL + PFE for your $10,000?
Drug Free Solution, Inc., a lifestyle company, delivers proprietary emotional wellness technology, known as Living Breath Process. Its Living Breath Process is a three-step process that combines self-analysis, breath, and language addressing various markets, including addiction/prevention, self help, emotional wellness, and lifestyle. The company also offers the Living Breath Series of programs with products, education, and services. Its Living Breath Project, through protocols, lifestyle enhancement products, training, and education, focuses on creating community wellness centers, wellness homes, and correctional facility support networks and centers that combine various offerings to diminish addiction and incarceration rates in the United States. The company was formerly known as Living Breath Project, Inc. and changed its name to Drug Free Solution, Inc. in January 2014. Drug Free Solution, Inc. is based in El Segundo, California.
Full DSOL Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.